THERMO FISHER SCIENTIFIC INC
For the period ended Mar 29, 2025. Filed May 2, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 29, 2025 · Filed May 2, 2025
TMO$718.20-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Income
| Three months ended | ||
|---|---|---|
| March 29, | March 30, | |
| (In millions except per share amounts) | 2025 | 2024 |
| Revenues | ||
| Product revenues | $5,980 | $5,955 |
| Service revenues | 4,384 | 4,390 |
| Total revenues | 10,364 | 10,345 |
| Costs and operating expenses: | ||
| Cost of product revenues | 3,125 | 2,939 |
| Cost of service revenues | 3,004 | 3,201 |
| Selling, general and administrative expenses | 2,078 | 2,183 |
| Research and development expenses | 342 | 331 |
| Restructuring and other costs | 98 | 29 |
| Total costs and operating expenses | 8,648 | 8,682 |
| Operating income | 1,716 | 1,663 |
| Interest income | 203 | 279 |
| Interest expense | (303) | (363) |
| Other income/(expense) | 3 | 10 |
| Income before income taxes | 1,620 | 1,589 |
| Benefit from/(provision for) income taxes | (95) | (281) |
| Equity in earnings/(losses) of unconsolidated entities | (14) | 23 |
| Net income | 1,511 | 1,331 |
| Less: net income/(losses) attributable to noncontrolling interests and redeemable noncontrolling interest | 4 | 4 |
| Net income attributable to Thermo Fisher Scientific Inc. | $1,507 | $1,328 |
| Earnings per share attributable to Thermo Fisher Scientific Inc. | ||
| Basic | $3.99 | $3.47 |
| Diluted | $3.98 | $3.46 |
| Weighted average shares | ||
| Basic | 378 | 382 |
| Diluted | 379 | 384 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.